###begin article-title 0
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
Variants of ST8SIA1 Are Associated with Risk of Developing Multiple Sclerosis
###end article-title 0
###begin p 1
Conceived and designed the experiments: MD SC EV. Performed the experiments: MD JR EV CY JF TM SH. Analyzed the data: MD JR EV. Contributed reagents/materials/analysis tools: SC JR EV. Wrote the paper: MD EV. Other: Drafting the article: MS.
###end p 1
###begin p 2
###xml 206 218 206 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA DR15/DQ6</italic>
###xml 566 573 566 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 838 850 838 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA DR15/DQ6</italic>
###xml 985 992 985 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 1224 1231 1224 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 857 865 <span type="species:ncbi:9606">patients</span>
###xml 906 911 <span type="species:ncbi:9606">child</span>
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system of unknown etiology with both genetic and environmental factors playing a role in susceptibility. To date, the HLA DR15/DQ6 haplotype within the major histocompatibility complex on chromosome 6p, is the strongest genetic risk factor associated with MS susceptibility. Additional alleles of IL7 and IL2 have been identified as risk factors for MS with small effect. Here we present two independent studies supporting an allelic association of MS with polymorphisms in the ST8SIA1 gene, located on chromosome 12p12 and encoding ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1. The initial association was made in a single three-generation family where a single-nucleotide polymorphism (SNP) rs4762896, was segregating together with HLA DR15/DQ6 in MS patients. A study of 274 family trios ( affected child and both unaffected parents) from Australia validated the association of ST8SIA1 in individuals with MS, showing transmission disequilibrium of the paternal alleles for three additional SNPs, namely rs704219, rs2041906, and rs1558793, with p = 0.001, p = 0.01 and p = 0.01 respectively. These findings implicate ST8SIA1 as a possible novel susceptibility gene for MS.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 118 121 118 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Steinman1">[1]</xref>
###xml 123 126 123 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Sospedra1">[2]</xref>
###xml 414 417 414 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-DeStefano1">[3]</xref>
###xml 419 422 419 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Barnett1">[4]</xref>
###xml 424 427 424 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Bjartmar1">[5]</xref>
###xml 711 714 711 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-McDonald1">[6]</xref>
###xml 456 464 <span type="species:ncbi:9606">patients</span>
Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system in young adults [1], [2]. A primary feature of MS is an inability of the brain to assert its inherent restorative potential to repair damage to myelin and oligodendrocytes. However, the severe irreversible clinical dysfunction is caused by a loss of axons that seems to occur even in early stages of the disease [3], [4], [5]. The disease begins in most patients with episodes of relapsing-remitting MS, and is often followed by a prolonged period of clinical remission. With time and repeated relapses, recovery is less complete and a gradual clinical progression known as "secondary progressive MS" occurs. [6]
###end p 4
###begin p 5
###xml 100 103 100 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Bjartmar1">[5]</xref>
###xml 105 108 105 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-DeStefano2">[7]</xref>
The mechanisms of demyelination and axonal injury are heterogeneous, complex and difficult to study [5], [7]. Although the morphology of the MS lesions can provide evidence for diagnosis, the pathophysiologies of individual plaques vary, making the disease process difficult to define. The main challenge in MS remains the understanding of pathological events that lead to initiation and evolution of the disease.
###end p 5
###begin p 6
###xml 180 183 180 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Hafler1">[8]</xref>
###xml 185 188 185 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Compston1">[9]</xref>
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Ebers1">[10]</xref>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Hafler2">[11]</xref>
###xml 331 338 331 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 379 386 379 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 592 596 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Nara1">[12]</xref>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Matsuda1">[13]</xref>
###xml 604 608 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Bieberich1">[14]</xref>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Kolter1">[15]</xref>
###xml 616 624 616 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002653-g001">Figure 1</xref>
###xml 982 986 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Kolter1">[15]</xref>
###xml 1080 1084 1080 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Bieberich1">[14]</xref>
###xml 1086 1090 1086 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Kolter1">[15]</xref>
###xml 1092 1096 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Tettamanti1">[16]</xref>
While there is evidence of the involvement of environmental risk factors, epidemiological twin and adoption studies also support a genetic component in the etiology of the disease [8], [9], [10] in which multiple interacting risk loci play a role [11]. Here we provide strong statistical genetic evidence of the involvement of the ST8SIA1 gene in conferring disease risk for MS. ST8SIA1 encodes GD3 synthase, a ubiquitously expressed type II transmembrane protein that generates GD3 ganglioside (GD3G) by catalyzing the addition of a second sialic acid residue to its immediate precursor GM3 [12], [13], [14], [15] (Figure 1). Gangliosides are amphipathic molecules composed of a ceramide lipid anchor attached to an externally oriented oligosaccharide chain of variable length and complexity. These lipids are the primary glycoconjugates on neurons and carry most of the sialic acid present in the brain. Ganglioside biosynthesis typically begins in the endoplasmic reticulum (ER) [15] and continues in the Golgi apparatus where resident glycosyltranferases complete the process [14], [15], [16]. The functional role of GD3 synthase in important brain functions and the identification of genetic variants associated with risk of MS may provide a new opportunity to decipher the mechanism of tissue injury in this disease.
###end p 6
###begin title 7
Partial ganglioside biosynthesis pathway scheme.
###end title 7
###begin p 8
###xml 107 118 107 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1gene</italic>
###xml 160 163 160 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-DeStefano1">[3]</xref>
The three key regulatory enzymes in ganglioside biosynthesis, GM3 synthase (1), GD3 synthase ((2) from the ST8SIA1gene), and N-acetylgalactosaminyltransferase ([3] GalNAcT) are shown. Ganglioside biosynthesis initiates with a stepwise glycosylation of ceramide (cer) to form glucosylceramide (GlcCer) and lactosylceramide (LacCer) mediated by the enzyme ceramide glucosyltransferase (CGT) and lactosylceramide synthase (LCS) respectively . The action of different sialyltransferases converts LacCer into gangliosides GM3 and then GD3G. Sequential addition of N-acetylgalactosamine (GalNac), galactose and sialic acid residues generate the a-series and b-series respectively.
###end p 8
###begin title 9
Results
###end title 9
###begin p 10
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Vitale1">[17]</xref>
###xml 214 226 214 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR15/DQ6</italic>
In a previous genome-wide linkage scan of a unique three-generation Pennsylvania Dutch family (PD) [17], we identified an 18 cM segment on chromosome 12p12 linked to MS in association with the HLA class II variant HLA-DR15/DQ6.
###end p 10
###begin p 11
###xml 29 37 29 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002653.s001">Table S1</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Vitale1">[17]</xref>
###xml 229 236 229 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 370 377 370 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 535 543 535 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002653-g002">Figure 2</xref>
###xml 604 611 604 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 861 873 861 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA DR15/DQ6</italic>
###xml 970 974 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Vitale1">[17]</xref>
###xml 1050 1058 1050 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002653-g002">Figure 2</xref>
###xml 1072 1084 1072 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA DR15/DQ6</italic>
###xml 1234 1246 1234 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA DR15/DQ6</italic>
###xml 1299 1311 1299 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA DR15/DQ6</italic>
###xml 839 847 <span type="species:ncbi:9606">patients</span>
DNA sequence analysis of 10 (Table S1) of the 94 known genes (NCBI ) contained in the 12p12 region linked to MS in the Pennsylvania Dutch (PD) family [17], identified a G/A polymorphism (rs4762896), at +29 in the intron 4 of the ST8SIA1 gene. Using high throughput sequencing analyses we screened promoter, coding regions and associated intronic splice junctions of the ST8SIA1 gene. The primer sequences and the sequence information are available upon request. We examined all seven affected as well as the 11 unaffected individuals (Figure 2). While a number of polymorphic variants were found, in the ST8SIA1 gene we did not identify other functional polymorphisms and mutations that could have been responsible for the association and only rs4762896, clearly proved to segregate with the affected individuals in this family. The seven patients also had the HLA DR15/DQ6 haplotype as previously described. In contrast, but in agreement with previous linkage analysis [17], three (134, 133, and 124) out of the nine at-risk unaffected individuals (Figure 2) carried the HLA DR15/DQ6 allele but did not carry the A allele of rs4762896, while three (137, 138, and 134) with the chromosome 12 haplotype, also had the A variant but not HLA DR15/DQ6. The remaining three (140, 139 and 168) had neither HLA DR15/DQ6 nor the A variant.
###end p 11
###begin title 12
PD family pedigree showing the SNP haplotype and HLA DR15/DQ6 genotype.
###end title 12
###begin p 13
Closed symbols are the subjects with clinically definite multiple sclerosis (CDMS) 132, 130,122,125,123,121, and clinically possible multiple sclerosis (CPMS) 131. A detailed neurological evaluation and lab test supported the diagnosis of MS. Open symbols are the healthy subjects. The results of the SNPs analyses are reported underneath each subject. The highlighted haplotype is composed of the same SNP alleles associated to risk of MS in the Australian trios.
###end p 13
###begin p 14
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 158 165 158 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
Given the supporting genetic data, we considered ST8SIA1 a promising candidate risk gene for MS and initiated an independent study for genetic association of ST8SIA1 SNPs in a large Australian MS population. MS cases used in this study were of North European Caucasian ancestry and selected based on the availability of both parents. Trios offer an advantage over case control studies since with association tests such as the transmission disequilibrium test (TDT), results are not affected by potential bias due to population stratification. The availability of parental genotypes also allows testing of specific hypotheses such as parent of origin effects, which cannot be tested in case-control samples.
###end p 14
###begin p 15
###xml 237 244 237 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Marrosu1">[18]</xref>
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Ebers2">[19]</xref>
###xml 461 469 <span type="species:ncbi:9606">children</span>
We genotyped the first 209 MS trios with the previously identified SNP located in intron 4 (rs4762896) and eight additional SNPs (rs704219, rs2041906, rs1558793, rs2193177, rs1019332, rs2160536, rs1861606, rs272882) that span the entire ST8SIA1 gene. Based on prior evidence of differential parental transmission [18], [19] of genetic variants in MS, we decided to test transmission of our candidate genes SNPs separately in mothers and fathers to the affected children.
###end p 15
###begin p 16
Given the initial sample size of 209 trios, we estimated that we had >80% power to detect an odds ratio (OR) of 1.8 or higher at p = 0.05.
###end p 16
###begin p 17
###xml 700 706 700 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA</italic>
Statistical analysis of data from these samples indicated significantly increased transmission of paternal alleles for rs704219 (p = 0.006), rs2041906 (p = 0.004) and rs1558793 (p = 0.03). All the other SNPs had TDT p-value >0.05 (data not shown). We then included 65 additional MS trios from Tasmania genotyped for the same three SNPs. The results showed the same trend and the combined data supported our initial observation (p = 0.001 for rs704219, p = 0.01 for rs2041906 and p = 0.01 for rs1558793 when considering only the paternal transmission). The SNP showing the strongest association with MS in the Australian trio population was rs704219 or C118T, a synonymous coding SNP in exon 5 of the ST8SIA gene. The result for rs704219 was due to overtransmission of the minor allele T from the unaffected fathers to offspring affected with MS (frequency of the T allele was 0.26 in transmitted, and 0.15 in un-transmitted paternal chromosomes). The odds-ratio for risk of MS based on the observed frequency of the T allele in transmitted and un-transmitted paternal chromosomes was 2.02 (95% CI 1.28-3.18).
###end p 17
###begin p 18
###xml 42 50 <span type="species:ncbi:9606">children</span>
###xml 567 575 <span type="species:ncbi:9606">patients</span>
###xml 663 671 <span type="species:ncbi:9606">patients</span>
###xml 889 897 <span type="species:ncbi:9606">patients</span>
HLA DR15/DQ6 typing was available for 273 children in the Australian trios. We tested interaction between the three SNPs typed in the extended Australian cohorts (rs704219, rs2041906, and rs1558793) and HLA DR15/DQ6 in two different ways. First, we divided the trios into DR15 positive (145) and negative (128) and repeated the TDT analysis separately in the two groups. Results were very similar between the two groups and in agreement with those observed in the two groups combined although less significant as expected given the smaller sample size (DR15-positive patients: fathers p-values: 0.01, 0.09, 0.02, mothers p-values: 0.74, 0.23, 0.41; DR15-negative patients: fathers p-values: 0.04, 0.06, 0.02, mothers p-values: 0.64, 0.88, 0.73). In addition, we performed a case-only analysis of interaction by comparing the three SNPs allele and genotype frequencies in the two groups of patients (145 DR15 positive and 128 DR15 negative). There were no significant differences in either allele or genotyping frequencies between the two group (all p-values >0.05). Thus results in the Australian cohort do not show evidence of statistical interaction between the two loci.
###end p 18
###begin p 19
###xml 108 115 108 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002653-t001">Table 1</xref>
###xml 120 128 120 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002653-g002">figure 2</xref>
Finally, haplotype analysis identified a partially shared haplotype between the PD family and the AU trios (Table 1 and figure 2), composed by the T allele of rs1558793 and the A allele of rs2041906.
###end p 19
###begin p 20
Freq-T: Frequency in transmitted chromosomes
###end p 20
###begin p 21
Freq-NT: Frequency in non transmitted chromosomes
###end p 21
###begin p 22
OR: odds-ratio
###end p 22
###begin title 23
Discussion
###end title 23
###begin p 24
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 203 210 203 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 288 300 288 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA DR15/DQ6</italic>
###xml 397 404 397 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 867 874 867 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 1095 1099 1095 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Luedi1">[20]</xref>
###xml 1235 1242 1235 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 1061 1066 <span type="species:ncbi:9606">human</span>
The results of two independent studies reported here provide evidence of a relationship between ST8SIA1 gene variants and the development of MS. The first analysis identified a SNP, rs4762896, at +29 of ST8SIA1 intron 4 in a three-generation family of MS individuals who also carried the HLA DR15/DQ6 haplotype. This SNP is included in the linkage critical region of the PD family. Involvement of ST8SIA1 was supported in a second study of 274 MS trios where paternal transmission of three additional SNPs in this gene, rs704219, rs2041906 and rs1558793, was associated with MS (p = 0.001, p = 0.01 and p = 0.01 respectively). In the AU cohort, the increased MS risk was related to preferential paternal transmission of the T allele for SNP rs704219 on 12p12. Although there are various mechanisms that can account for paternal transmission, our results suggest that ST8SIA1 may be an MS susceptibility gene possibly regulated by genomic imprinting. In this regard a recent study using a computational method for predicting the genome-wide imprinting status of human genes was recently reported [20] and this identified an imprinting effect between two genes, RBP5 and ABCC9, on 12p13 and 12p12 respectively, the precise region of the ST8SIA1 gene.
###end p 24
###begin p 25
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Haines1">[21]</xref>
###xml 401 407 401 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA</italic>
###xml 720 725 720 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 730 735 730 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL7RA</italic>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Hafler2">[11]</xref>
###xml 753 757 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Lundmark1">[22]</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Lundmark2">[23]</xref>
###xml 439 447 <span type="species:ncbi:9606">patients</span>
The variants described here are not rare mutations, rather they are polymorphisms that are common in normal populations. Our data strongly indicate that sporadic and familial MS share at least one common genetic susceptibility and that studies of familial MS will help our understanding of sporadic MS, as well as confirm the genetic heterogeneity already reported [21]. Our results show that certain ST8SIA variants are more common in MS patients from AU and affect disease risk when paternally transmitted with an odds-ratio of 2.02 for the minor allele (T) of rs704219. Consequently, the effect of rs704219 on disease risk could be greater than that previously reported for risk associated variation in the genes for IL2RA and IL7RA (OR = 1.2) [11], [22], [23].
###end p 25
###begin p 26
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 137 144 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 346 353 346 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Kantarci1">[24]</xref>
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Herrera1">[25]</xref>
###xml 706 710 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Ramagopalan1">[26]</xref>
In conclusion, our data support a role for the ST8SIA1 gene as a contributing factor in MS. Our studies had the advantage of identifying ST8SIA1 in a unique single multiplex family affected by MS. We were then able to examine SNPs of this gene in a collection of sporadic MS cases and their parents from Australia. The study confirmed a role for ST8SIA1 variants in this MS population and indicated preferential paternal transmission. While some [24] have found a preferential transmission of MS from affected fathers to their offspring, others [25] have not confirmed these results. Parental effect has been recently reported as a feature of the MHC as shown by the maternal influence in disease etiology [26]. Our study used trios in which parents were unaffected and prior identification of a specific risk gene variant had been made.
###end p 26
###begin p 27
Outside of the immunoregulatory system, this is the first gene extensively involved in neuronal function and membrane structure to be implicated with MS. Having identified a specific protein and its variants associated with MS allows a new approach towards understanding the molecular physiopathology of the disease. Further studies are needed to confirm and expand upon our results.
###end p 27
###begin title 28
Methods
###end title 28
###begin title 29
Sample collection
###end title 29
###begin p 30
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Vitale1">[17]</xref>
###xml 1014 1018 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Lassmann1">[27]</xref>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
###xml 601 609 <span type="species:ncbi:9606">patients</span>
###xml 751 759 <span type="species:ncbi:9606">patients</span>
The blood samples were collected in preservative-free ACD tubes under an IRB-approved protocol. DNA was extracted using the QIAmp DNA extraction kit (QIAGEN Inc. USA). The detailed clinical data of this family are reported elsewhere [17]. In summary six patients had clinically definite MS (CDMS-132, 130, 122, 125, 123, 121; only one had clinically probable MS (CPMS-131) after neurological evaluation (history, neurological exam, laboratory testing). The phenotypic expression and temporal profile of the disease were quite varied with regard to age of onset (24 to 33 years), clinical course (four patients were relapsing-remitting, two were secondary progressive, one was primary progressive) and anatomical location of the lesions (cerebral [six patients], optic nerve [five], cerebellum [five], brain stem [three], and spinal cord [six]). All had abnormal magnetic resonance imaging (MRI) scans consistent with MS and four of them also had abnormal cerebrospinal fluid (CSF) profiles also consistent with MS [27].
###end p 30
###begin p 31
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Poser1">[28]</xref>
###xml 384 388 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Paty1">[29]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Polman1">[30]</xref>
###xml 58 63 <span type="species:ncbi:9606">child</span>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
###xml 769 774 <span type="species:ncbi:9606">Human</span>
###xml 827 832 <span type="species:ncbi:9606">Human</span>
Genomic DNAs from 209 sporadic MS trio families (affected child, unaffected parents) from the Australian State of Victoria and 65 similar MS trios from the island State of Tasmania were genotyped. All patients included in the study were diagnosed as having either clinically definite MS or laboratory-supported definite MS or definite MS according to standard clinical criteria [28], [29], [30]. Recruitment and phenotyping of the Australian MS families were conducted by members of The Southern MS Genetics Consortium; Trevor Kilpatrick, Simon Foote, Helmut Butzkueven, Bruce Taylor, Niall Tubridy, Mark Marriott, Caron Chapman, Melanie Bahlo, Terry Speed and Jim Stankovich. All subjects were recruited according to guidelines approved by either The Melbourne Health Human Research Ethics Committee or the Southern Tasmanian Human Research Ethics Committee.
###end p 31
###begin title 32
SNP analysis
###end title 32
###begin p 33
###xml 113 120 113 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST8SIA1</italic>
We performed SNPs analyses in the family using a Beckman Coulter CEQ 8000 system. The regions of interest in the ST8SIA1 gene were PCR amplified. Primer 3 software was used to design the primers. Genomic DNA (100ng) in 25 microl PCR reaction mixture of 1X buffer (Tris-CL, KCL, (NH4)2 SO4, 15mM Mgcl2; pH8.7), 1 X Q-solution, 200 microM of dNTP, 20pmole of each primer and 2.5U of Taq DNA polymerase (QIAGEN Inc. USA). The PCR mixture was denatured for 5 min at 94degreesC and cycled 31 times (94degreesC for 30 sec, 55degreesC for 1.15 min and 72degreesC for 15 sec), followed by a 10 min extension at 72degreesC. Post reaction template was cleaned up by directly adding 2 U SAP (Roche) and 1U Exo I (MBI Fermentas), to 6ul of PCR product and incubating at 37degreesC for 1 hour and 75degreesC for 15 min. The standard protocol of CEQ SNP-primer extension reaction kit was used: 100ng template DNA, 1pmole SNPs Interrogation Primers, 11 microl of SNP-primer extension premix, to a final volume of 20 microl. The reaction mixture was thermocycled at 96degreesC 10 sec, 50degreesC 5 sec and 72degreesC 30 sec for 25 cycles. Additional clean up of the extended products was done by incubation with 1U SAP at 37degreesC for 1 hour and 75degreesC for 15 min; 0.5 microl of the purified SNP reaction to 0.5 microl size standard 80 (P/N 608395) and 39 microl of sample loading solution, to final volume of 40 microl for each in the CEQ sample plate (P/N 609801) and loaded. We used DNAs NA07057 and NA06990 from CEPH/UTAH pedigree 1331 (Coriell Cell Repositories) as normal controls. The Australian MS trio families were genotyped using the SEQUENOM platform at The Australian Genome Research Facility
###end p 33
###begin title 34
Genes Sequences
###end title 34
###begin p 35
We designed intronic primers flanking each of the exons for all the genes located in the critical interval, using Primer3 software. PCR amplification was performed using a QIAGEN kit and GC Rich system (Roche) for GC rich sequences. We examined amplified products on 1% agarose gels and purified them for sequencing using QIAquick PCR Purification Kit (QIAGEN). We sequenced PCR products using the CEQ Dye Terminator Cycle Sequencing with Quick start kit (Beckman Coulter) and analyzed them on Beckman Coulter CEQ 8000 Genetic analysis system. We sequenced both strands of each product using DNA from all the family members. Control DNAs C1 (NA07057) and C2 (NA06990) from CEPH/UTAH pedigree 1331 (Coriell Cell Repositories) was sequenced as well. Analysis was done by Chromas Sequence Analysis software.
###end p 35
###begin title 36
Statistics
###end title 36
###begin p 37
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002653-Dudbridge1">[31]</xref>
###xml 220 228 <span type="species:ncbi:9606">children</span>
Association of SNP alleles with disease status was tested by means of the transmission disequilibrium test using the software Unphased [31]. Frequencies of transmitted and nontransmitted alleles from parents to affected children were estimated from parental chromosomes and used to calculate allelic odds-ratios and their confidence intervals.
###end p 37
###begin title 38
Supporting Information
###end title 38
###begin p 39
table gene's
###end p 39
###begin p 40
(0.07 MB DOC)
###end p 40
###begin p 41
Click here for additional data file.
###end p 41
###begin p 42
Many thanks to Dr. Peter Tolias for editing the paper.
###end p 42
###begin title 43
References
###end title 43
###begin article-title 44
Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system.
###end article-title 44
###begin article-title 45
Immunology of multiple sclerosis.
###end article-title 45
###begin article-title 46
###xml 36 44 <span type="species:ncbi:9606">patients</span>
Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability.
###end article-title 46
###begin article-title 47
The pathology of multiple sclerosis: a paradigm shift.
###end article-title 47
###begin article-title 48
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.
###end article-title 48
###begin article-title 49
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.
###end article-title 49
###begin article-title 50
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.
###end article-title 50
###begin article-title 51
Multiple sclerosis.
###end article-title 51
###begin article-title 52
The genetic epidemiology of multiple sclerosis.
###end article-title 52
###begin article-title 53
A population-based study of multiple sclerosis in twins.
###end article-title 53
###begin article-title 54
Risk alleles for multiple sclerosis identified by a genomewide study.
###end article-title 54
###begin article-title 55
###xml 126 131 <span type="species:ncbi:9606">human</span>
Expression cloning of a CMP-NeuAc:NeuAc alpha 2-3Gal beta 1-4Glc beta 1-1'Cer alpha 2,8-sialyltransferase (GD3 synthase) from human melanoma cells.
###end article-title 55
###begin article-title 56
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Chromosome mapping of the GD3 synthase gene (SIAT8) in human and mouse.
###end article-title 56
###begin article-title 57
Regulation of ganglioside biosynthesis by enzyme complex formation of glycosyltransferases.
###end article-title 57
###begin article-title 58
Combinatorial ganglioside biosynthesis.
###end article-title 58
###begin article-title 59
Ganglioside/glycosphingolipid turnover: new concepts.
###end article-title 59
###begin article-title 60
Linkage analysis conditional on HLA status in a large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12.
###end article-title 60
###begin article-title 61
Bias in parental transmission of the HLA-DR3 allele in Sardinian multiple sclerosis.
###end article-title 61
###begin article-title 62
Parent-of-origin effect in multiple sclerosis: observations in half-siblings.
###end article-title 62
###begin article-title 63
###xml 55 60 <span type="species:ncbi:9606">human</span>
Computational and experimental identification of novel human imprinted genes.
###end article-title 63
###begin article-title 64
Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group.
###end article-title 64
###begin article-title 65
Genetic association analysis of the interleukin 7 gene (IL7) in multiple sclerosis.
###end article-title 65
###begin article-title 66
Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.
###end article-title 66
###begin article-title 67
###xml 0 3 <span type="species:ncbi:9606">Men</span>
###xml 36 44 <span type="species:ncbi:9606">children</span>
###xml 48 53 <span type="species:ncbi:9606">women</span>
Men transmit MS more often to their children vs women: the Carter effect.
###end article-title 67
###begin article-title 68
Parental transmission of MS in a population-based Canadian cohort.
###end article-title 68
###begin article-title 69
Parental transmission of HLA-DRB1*15 in multiple sclerosis.
###end article-title 69
###begin article-title 70
Neuropathology in multiple sclerosis: new concepts.
###end article-title 70
###begin article-title 71
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
###end article-title 71
###begin article-title 72
MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.
###end article-title 72
###begin article-title 73
Multiple sclerosis diagnostic criteria: three years later.
###end article-title 73
###begin article-title 74
Pedigree disequilibrium tests for multilocus haplotypes.
###end article-title 74
###begin p 75
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 75
###begin p 76
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the MS National Multiple Sclerosis Society, the Wadsworth Foundation for Multiple Sclerosis Research Grant and the Foundation of UMDNJ(E.V.) and by Segal Family, L'Hommedieu and Kushner Family Grants (S.C.). JPR is an R. D. Wright Fellow of The National Health and Medical Research Council of Australia.
###end p 76

